What is RDHL's relative strength rating?

RDHL ranks at the 13th percentile over 1 month, 9th percentile over 3 months, 13th percentile over 6 months, 14th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.

What sector is RDHL in?

RDHL is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is RDHL in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). RDHL benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is RDHL?

RDHL currently shows a 20-day average daily range (ADR%) of 7.8%, a 90-day beta versus the S&P 500 of -0.03. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.

Does RDHL have a seasonal pattern?

TickerStance computes RDHL's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what RDHL has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did RDHL last report earnings?

No SEC EDGAR filings are linked to RDHL in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Redhill Biopharma Ltd. (RDHL) · RS 13

TODAY'S READ · AS OF 2026-08-25

As of 2026-08-25, Redhill Biopharma Ltd. (RDHL) has a 3-month relative strength percentile of 9 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 35. The current market Stance is 52.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 7.8%, relative volume 0.14×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month9pctile

6 month13pctile

1 year14pctile

Classic9IBD pctile

LDR7leadership

0 of 5 lenses lit · avg RS pctile 10

✓ADR%7.8%!A/DE!RVOL0.14×!$ Vol$69K

COMPUTED · AS OF 2026-08-25

Pattern read

RDHL is in a stage 4 downtrend, week 11. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -14.5% / -36.5%.

Pure factual computation. Not a recommendation. See stage analysis.

Market backdrop

52.9Neutral

Trend30% weight47.0 Breadth30% weight56.3 Leadership20% weight42.0 Macro20% weight60.3 Full stance breakdown →

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

13

3m

9

6m

13

1y

14

LDR

—

StageWeinstein stage analysis

Stage 4 · Decline✓

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

A/D ratingaccumulation / distribution

E

RVOL todayvs 50d avg

0.14×

U/D ratiolast 50 sessions

1.82

Breakout volbreakout day vs 50d avg

-95%

50d avg $ volumeliquidity proxy

$69K

Risk profile

How much does it move?

Daily range, ATR, beta, and the math for a 1-ADR stop.

ADR% (20d)avg daily range

7.8%Elevated

ATR(14)14-day EMA

$0.05

ATR%ATR as % of close

8.10%

Beta vs SPY90d rolling

-0.03

1-ADR stoprisk from close $0.61

$0.56−7.8%

Fundamentals · RDHL

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m
RDHL
9RS 3m · you

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials55

Real Estate45

Consumer Staples36

RS pctileLagLead

PEERS · Pharmaceutical Products

Same industry, closest relative strength

4 peers · by RS6M

CELUCelularity Inc. Class A Common Stock13 COLLCollegium Pharmaceutical, Inc. Common Stock12 CATXPerspective Therapeutics, Inc.12 ESLAEstrella Immunopharma, Inc. Common Stock13

§ Seasonality

10y · since 2022

Best monthNov on averageavg +74.03% · 50% win · n 4

Worst monthDec on averageavg -32.28% · 0% win · n 4

RDHL monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	RDHL Jan avg: 2.18% median: 6.80% win: 50% σ: 48.46% n: 4 2022-04-12 → 2026-07-31	RDHL Feb avg: -13.51% median: -8.30% win: 50% σ: 23.44% n: 4 2022-04-12 → 2026-07-31	RDHL Mar avg: -28.03% median: -21.65% win: 0% σ: 18.29% n: 4 2022-04-12 → 2026-07-31	RDHL Apr avg: -9.76% median: -18.61% win: 20% σ: 32.80% n: 5 2022-04-12 → 2026-07-31	RDHL May avg: -11.82% median: -8.26% win: 20% σ: 15.17% n: 5 2022-04-12 → 2026-07-31	RDHL Jun avg: -19.36% median: -19.08% win: 20% σ: 20.18% n: 5 2022-04-12 → 2026-07-31	RDHL Jul avg: -9.05% median: 0.00% win: 40% σ: 17.57% n: 5 2022-04-12 → 2026-07-31	RDHL Aug avg: -9.12% median: -4.21% win: 50% σ: 16.39% n: 4 2022-04-12 → 2026-07-31 (current)	RDHL Sep avg: -5.62% median: -19.54% win: 50% σ: 49.24% n: 4 2022-04-12 → 2026-07-31	RDHL Oct avg: -5.00% median: -9.19% win: 25% σ: 32.57% n: 4 2022-04-12 → 2026-07-31	RDHL Nov avg: 74.03% median: -2.27% win: 50% σ: 184.60% n: 4 2022-04-12 → 2026-07-31	RDHL Dec avg: -32.28% median: -26.97% win: 0% σ: 20.09% n: 4 2022-04-12 → 2026-07-31

Public attention · RDHL

Is the crowd watching?

49/ 100 · vs its own 90-day norm▲ 31 vs 7dOverlooked

Weak relative strength and quiet attention. Little to read here either way.

Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.

News

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2834

Floatn/a

Shares out6.1Mshares

Market cap$3.7MNano Cap

FAQ

Frequently asked questions

What is RDHL's relative strength rating?: RDHL ranks at the 13th percentile over 1 month, 9th percentile over 3 months, 13th percentile over 6 months, 14th percentile over 1 year against the full TickerStance CS+ADRC universe of U.S. equities.
What sector is RDHL in?: RDHL is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is RDHL in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). RDHL benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is RDHL?: RDHL currently shows a 20-day average daily range (ADR%) of 7.8%, a 90-day beta versus the S&P 500 of -0.03. An ADR% above 4% indicates an intraday swing-trading eligible name in the Minervini Volatility Contraction Pattern framework. ADR% and ATR% are updated daily; beta is computed over a trailing 90-day window.
Does RDHL have a seasonal pattern?: TickerStance computes RDHL's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what RDHL has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.
When did RDHL last report earnings?: No SEC EDGAR filings are linked to RDHL in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Redhill Biopharma Ltd. (RDHL) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Redhill Biopharma Ltd. (RDHL) — Stance & relative strength

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

§ Seasonality

Is the crowd watching?

Company snapshot

Frequently asked questions

§ Seasonality

Redhill Biopharma Ltd. (RDHL) — Stance & relative strength

RDHL is not confirmed as a leader. 9 is not yet a leadership-grade RS read, Market Stance is 52.9

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions

Redhill Biopharma Ltd. (RDHL) — Stance & relative strength

RDHL is not confirmed as a leader. 9 is not yet a leadership-grade RS read, Market Stance is 52.9

Lenses lit

Pattern read

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

How much does it move?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Same industry, closest relative strength

Is the crowd watching?

Company snapshot

Frequently asked questions